Vimarsana
Biggest News Aggregation in the World

Page 7 - Collective Coordinates News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Collective Coordinates. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Collective Coordinates Today - Breaking & Trending Today

ProMIS Neurosciences (OTCMKTS:ARFXF) Reaches New 1-Year High at $5.34 - Vimarsana News

ProMIS Neurosciences (OTCMKTS:ARFXF) Reaches New 1-Year High at $5.34

ProMIS Neurosciences, Inc. (OTCMKTS:ARFXF – Get Rating)’s stock price hit a new 52-week high during trading on Monday . The company traded as high as $5.34 and last traded at $5.00, with a volume of 1543 shares traded. The stock had previously closed at $5.10. ProMIS Neurosciences Stock Down 2.0 % The firm has a […]

Beldex Trading Up 1.9% Over Last 7 Days (BDX) - Vimarsana News

Beldex Trading Up 1.9% Over Last 7 Days (BDX)

ProMIS Neurosciences, Inc. (TSE:PMN – Get Rating) shares were up 1.5% during mid-day trading on Friday . The stock traded as high as C$6.94 and last traded at C$6.80. Approximately 1,300 shares traded hands during trading, a decline of 10% from the average daily volume of 1,449 shares. The stock had previously closed at C$6.70. […]

ProMIS Neurosciences (OTCMKTS:ARFXF) Sets New 12-Month High at $5.22 - Vimarsana News

ProMIS Neurosciences (OTCMKTS:ARFXF) Sets New 12-Month High at $5.22

ProMIS Neurosciences, Inc. (OTCMKTS:ARFXF – Get Rating)’s stock price reached a new 52-week high during trading on Monday . The company traded as high as $5.22 and last traded at $4.89, with a volume of 9241 shares traded. The stock had previously closed at $5.07. ProMIS Neurosciences Stock Performance The company has a market capitalization […]

Lead Therapeutic Candidate, PMN310, Demonstrates Enhanced Selectivity for Toxic Oligomers Compared to Other Amyloid-Beta-Directed Antibodies in Poster Presentation at AD/PD 2023 - Vimarsana News

Lead Therapeutic Candidate, PMN310, Demonstrates Enhanced Selectivity for Toxic Oligomers Compared to Other Amyloid-Beta-Directed Antibodies in Poster Presentation at AD/PD 2023

TORONTO, Ontario and CAMBRIDGE, Massachusetts, March 29, 2023 -- ProMIS Neurosciences Inc. , a biotechnology company focused on the generation and development of antibody therapeutics... | March 29, 2023

Lead Therapeutic Candidate, PMN310, Demonstrates Enhanced Selectivity for Toxic Oligomers ... - Vimarsana News

Lead Therapeutic Candidate, PMN310, Demonstrates Enhanced Selectivity for Toxic Oligomers ...

TORONTO, Ontario and CAMBRIDGE, Massachusetts, March 29, 2023 (GLOBE NEWSWIRE) -- ProMIS Neurosciences Inc. (TSX: PMN) (Nasdaq: PMN), a biotechnology company focused on the generation and development of antibody therapeutics